By PAUL VON BÜNAU Fully digitised, AI-directed, in-silico drug discovery and development programs are not…

By PAUL VON BÜNAU Fully digitised, AI-directed, in-silico drug discovery and development programs are not…
By BENJAMIN HÄUSLER and RAPHAEL SCHYMCZYK Linkage disequilibrium score regression is already being put to…
By PAUL VON BÜNAU Immense development costs and low success rates can make drug development…
By PAUL VON BÜNAU DeepMind AI’s impressive protein structure prediction accuracy hints at a huge…